MM21: Mastering Venture Capital in a Volatile Market: Insights from a Life Science Investor
Listen now
Description
Venture capital funding is drying up, but is this a crisis or an opportunity?  Squire Servance, founder of Syridex Bio,, explains the "denominator problem," why savvy investors are targeting overlooked assets, and how his fund addresses health disparities. Link to full episode Support the Show. Join the Podcast Newsletter: Link
More Episodes
Ever wondered what drives Elon Musk, the world's most controversial innovator? This biography summary by Walter Isaacson dives into the complex mind of the man behind rockets, EVs, and the Twitter takeover. In my martial arts days, a coach taught me to study exceptional role models – a strategy...
Published 05/10/24
🚀 Investing with Impact: Squire Servance on Health Equity & Venture Capital Unlock the power of venture capital to address health disparities and drive positive social change.  In this insightful episode, we speak with Squire Servance, founder of health equity fund Syridex Bio.  Discover his...
Published 04/19/24
Published 04/19/24